TTNP News and Press, Titan Pharmaceuticals Inc. From 07/27/23

SAN FRANCISCO, July 27, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered into an Asset Purchase Agreement (the “Agreement”) with Fedson, Inc., a Delaware Corporation (“Fedson”), for the s...

Signs Non-Binding Letter of Intent for Transformational Transaction Continues to Make Substantial Progress on Strategic Transactions Including Sale of Existing Assets SAN FRANCISCO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or t...

SAN FRANCISCO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has granted an exclusive license to Ocular Therapeutix Inc. (“Ocular”) pertaining to certain patent applications for ophthalmic uses in ...

Titan Pharmaceuticals ( NASDAQ: TTNP ) said it granted an exclusive license to Ocular Therapeutix related to certain patent applications for ophthalmic uses in humans and nonhuman animals in the U.S. Under the agreement, Ocular will pay Titan an upfront fee with the pote...

3 Industries That Penny Stocks Investors Are Watching If you’re looking for industries to find penny stocks to buy, there are a few that penny stock investors are watching right now. While there are dozens of industries for investors to choose from, it all comes down to knowing y...

Buying Penny Stocks on July 8th? Here’s What You Need to Know If you’re thinking about buying penny stocks on July 8th, there is a lot to know. For starters, we know that there is a considerable amount of volatility in the stock market right now. This is the result of risi...

Penny stocks are shares of companies trading for less than $5 and have offered speculative potential during the stock market crash this year. They’re known for their high-risk and high reward, and when it comes to a choppy stock market, as we’ve seen recently, traders seek...

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant PR Newswire SOUTH SAN FRANCISCO, Calif. , July 5, 2022 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that t...

Investment fund Activist Investing LLC on Friday said that it had increased its stake in Titan Pharmaceuticals (NASDAQ:TTNP) to 9.9%. Activist Investing CEO David Lazar said that the stake increase was "a result of our belief in the prospects of the company and its ability to unlock significa...

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest stockholders of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“TTNP...